"C I" Pill Images
The following drug pill images match your search criteria.
LOTENSIN HCT 454 454
1 / 2
Loading
CIPLA 322
Dimethyl Fumarate Delayed-Release
- Strength
- 120 mg
- Imprint
- CIPLA 322
- Color
- Green & White
- Shape
- Capsule/Oblong
![Pill medicine White Capsule/Oblong is Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release](/img/pillid/no-image-placeholder.png)
- Strength
- 60 mg / 120 mg
- Color
- White
- Shape
- Capsule/Oblong
![Pill ZESTORETIC 141 Orange Round is Zestoretic](https://www.drugs.com/images/pills/mmx/t101807f/zestoretic.jpg)
1 / 4
Loading
ZESTORETIC 141
![Pill MOTRIN SINUS HEADACHE Capsule/Oblong is Motrin sinus headache](https://www.drugs.com/images/pills/mmx/t102570f/motrin-sinus-headache.jpg)
MOTRIN SINUS HEADACHE
Motrin sinus headache
- Strength
- 200 MG-30 MG
- Imprint
- MOTRIN SINUS HEADACHE
- Shape
- Capsule/Oblong
![Pill 011 Schering Logo Pink Round is Celestone](/img/pillid/no-image-placeholder.png)
011 Schering Logo
![Pill SCHERING logo 496 White Round is Fulvicin U/F](https://www.drugs.com/images/pills/mmx/t103643f/fulvicin-u-f.jpg)
1 / 2
Loading
SCHERING logo 496
Fulvicin U/F
- Strength
- microcrystalline 500 mg
- Imprint
- SCHERING logo 496
- Color
- White
- Shape
- Round
LCI 1410
Esterified Estrogens and Methyltestosterone
- Strength
- 0.625 mg / 1.25 mg
- Imprint
- LCI 1410
- Color
- Green
- Shape
- Oval
![Pill Pfizer CDT 054 White Oval is Amlodipine Besylate and Atorvastatin Calcium](https://www.drugs.com/images/pills/mtm/597626722_PB.jpg)
1 / 5
Loading
Pfizer CDT 054
Amlodipine Besylate and Atorvastatin Calcium
- Strength
- 5 mg / 40 mg
- Imprint
- Pfizer CDT 054
- Color
- White
- Shape
- Oval
![Pill LCI 16 50 White Oval is Acetaminophen and Hydrocodone Bitartrate](https://www.drugs.com/images/pills/custom/pill26320-1/acetaminophen-and-hydrocodone-bitartrate.jpg)
LCI 16 50
Acetaminophen and Hydrocodone Bitartrate
- Strength
- 325 mg / 7.5 mg
- Imprint
- LCI 16 50
- Color
- White
- Shape
- Oval
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.